Adherence to Pharmacotherapy in Patients Admitted for Inpatient Treatment at the Scientific Medical Center (PRIMULA)

Active, not recruiting

• Conditions: Cardiovascular Diseases

• Registration Number: NCT07040800
• Lead Sponsor: National Medical Research Center for Therapy and Preventive Medicine

Brief Summary

This cross-sectional observational study will assess adherence to previously prescribed medication in patients admitted to inpatient treatment at the scientific medical center. When filling out the questionnaire, the previously prescribed pharmacotherapy, the regularity of medication intake and the presence of side effects of drug treatment, if any, according to their medical history will be clarified.

Detailed Description

Not available

Study Timeline

• Study Start: 2025-02-19
• Status Verified: 2025-06
• Study First Submitted: 2025-06-09
• Study First Submitted QC: 2025-06-26
• Last Update Submitted: 2025-06-26
• Study First Posted: 2025-06-27
• Last Update Posted: 2025-06-27
• Primary Completion: 2026-02-19
• Study Completion: 2026-02-19

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 5000

Inclusion Criteria

• all patients admitted to the scientific center, signed patients' informed consent

Exclusion Criteria

• patient's unsigned informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of patients with NSEPh adherence score ≥3 (i.e., complete secondary or complete primary non-commitment) at baseline	Baseline	Commitment to treatment was determined using the National Society of Evidence-Based Pharmacotherapy (NSEPh) adherence scale.; Based on the scores obtained, patients are categorized as follows: * 0 points - full adherence; * 1 point - partial (incomplete) non-commitment, unintentional violations; * 2 points - partial (incomplete) non-commitment, intentional violations (including self-medication); * 3 points - complete secondary non-commitment; * 4 points - complete primary non-commitment The threshold for defining non-adherence was set at ≥3 points.

Trial Locations

Locations (1)

National Medical Research Centre for Therapy and Preventive Medicine; 🇷🇺 Moscow, Russian Federation